arrow
F

Frank Ruschitzka

university of zurich
H指数:119
被引数:16.0万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heart failure guideline-directed medical therapy in young adults with dystrophin-related cardiomyopathy: the HOPE-MD registry

肌营养不良相关心肌病年轻成年患者中的心力衰竭指南导向药物治疗:HOPE-MD登记研究

2026-05-210
PRE
Clinical radiation audits as a tool for the optimization of radiation exposure in cardiac electrophysiology procedures

临床辐射审计作为优化心脏电生理操作中辐射暴露的工具

2026-05-011
OAAI
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial

肾功能障碍对ST段抬高型心肌梗死患者非罪犯病变即刻与分阶段血运重建的影响:随机MULTISTARS AMI试验的预先指定亚组分析

2026-03-090
PRE
Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk: a cardinality-matched comparison with direct oral anticoagulation on long-term stroke and bleeding rates

心房颤动伴高出血风险患者左心耳封堵的安全性与有效性:与直接口服抗凝剂在长期卒中及出血率方面的基数匹配比较

2025-10-010
OAAI
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention

糖尿病对接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死合并多支血管冠状动脉疾病患者预后的影响

2025-09-100
OAAI
Angiotensin–Neprilysin Inhibition and Left Ventricular Assist Device Therapy –Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

血管紧张素-中性肽链内切酶抑制与左心室辅助装置疗法——多中心、随机、开放标签、平行组研究评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中应用的主要结果(ENVAD-HF)

2025-08-310
OAAI
Myocardial characterization using late enhancement photon-counting detector CT in ventricular arrhythmia: comparison with electroanatomical mapping

使用晚期增强光子计数探测器CT进行心肌特征分析在室性心律失常中的应用:与电解剖标测的比较

2025-08-290
OAAI
Rationale, design and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)

研究背景、设计与基线特征:一项多中心、随机、开放标签、平行分组研究,旨在评估沙库巴曲/缬沙坦在HeartMate 3 LVAD受者中的使用(ENVAD-HF研究)。

2025-08-140
PREAI
Enhanced coronary physiology assessment with endothelial shear stress predicts residual cardiovascular risk in older patients with myocardial infarction

内皮切应力增强的冠状动脉生理学评估可预测心肌梗死老年患者的残余心血管风险

2025-08-130
PRE
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC

心房心肌病:从健康心房到心房衰竭。欧洲心脏病学会心力衰竭协会临床共识声明

2025-08-050
OAAI